My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
November 2017
POLICY AND ADVOCACY
FY2018 Funding News

The federal government is now operating on a Continuing Resolution through December 8, with a final funding bill for the new fiscal year yet to be determined by Congress. Over the summer, the House and Senate Appropriations Committees provided increases or flat funding for key IDSA and HIVMA priorities at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration, Biomedical Advanced Research and Development Authority, State Department, and the US Agency for International Development.

While this was good news, Congress must still come up with a bipartisan budget agreement that provides relief from sequestration cuts and spending caps and then pass a final omnibus appropriations bill. IDSA is making the case for a bipartisan budget agreement and a final FY2018 omnibus funding bill. We recently urged House and Senate Appropriations Committee chairs and ranking members to move forward immediately and include robust resources for ID/HIV programs.

Additionally, Congress is currently negotiating final legislation to renew Department of Defense (DoD) programs for the next fiscal year. IDSA and HIVMA are concerned that provisions in the Senate version of the bill would severely restrict vital DoD ID/HIV research. IDSA and HIVMA are working to oppose these onerous restrictions.

Take Action to Protect Medical Research at DoD

We have told Congress about our opposition to these DoD provisions and we are urging IDSA and HIVMA members to do the same.

As the appropriations process presses on, IDSA and HIVMA will advocate for full funding for our priority programs across the federal government.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
HIVMA Releases Guideline on HIV and Chronic Pain
ACIP Makes New Recommendations on Shingles, Mumps Vaccines
Weighing in on HHS Report on Vaccine Innovation
Updates on NIHís Next Generation Researchers Initiative
CLINICAL PRACTICE MANAGEMENT
IDSA to UHC: Donít Deny Payment for Cognitive Services
Reimbursement for Telemedicine Could Get Easier
How to Stay Abreast of CMSís Quality Payment Program
POLICY AND ADVOCACY
IDSA Remains Committed to Fighting Antimicrobial Resistance
FY2018 Funding News
IDSA Continues to Press for Diagnostics Reimbursement
FDA Public Workshop on Antimicrobial Susceptibility Tests
IDSA Member Testifies at New York State Hearing on Lyme Disease
GLOBAL HEALTH
Science Speaks Covers IDWeek, Union World Conference on Lung Health
Congressional Study Tour to CDC Global Health
EDUCATION AND RESOURCES
Fellowship in Stewardship and Resistance Receives CDC Funding
HIVMA Clinical Fellowship and Medical Students Program
PCORI Funding Announcement: Community-Acquired Pneumonia
FROM THE PRESIDENT
Maintaining Our Momentum
TOP STORIES
IDSA Launches Antimicrobial Stewardship Centers of Excellence Program
Updated Guideline on Infectious Diarrhea Now Available
IDWeek 2017 Recap
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.